About 50% of human melanomas are strongly associated with BRAF mutations, which renders tumour patients with this type of melanoma usually have high immunosuppression and resistance to vaccine treatment (Junttila and de Sauvage 2013). The gene discussed is BRAF; the disease is melanoma.